The pathogenesis of exercise induced bronchoconstriction is likely multifactorial and is not completely understood.

运动诱发型支气管收缩的致病原因可能是多方面的，目前还未完全了解。

Conclusion Loratadine and ketotifen can inhibit the exercise-induced bronchoconstriction in guinea pigs pretreated with LPS and metyrapone.

结论在用脂多糖和甲吡丙酮预处理的运动性哮喘豚鼠模型中，氯雷他定和酮替芬能够抑制支气管收缩。

The management of exercise induced bronchoconstriction focuses on prevention, through both pharmacologic and non-pharmacologic interventions.

运动诱发支气管收缩的处置首重经由药物和非药物介入防止其发作。

Exercise-induced bronchoconstriction (EIB) following strenuous physical exertion afflicts many people.

运动诱发的支气管收缩（EIB）伴随着大量的体力消耗，折磨着许多人。

Mast cell stabilizing agents are effective in attenuating exercise-induced bronchoconstriction but their effectiveness compared to bronchodilator agents is unclear.

肥胖细胞稳定剂可以有效减少运动诱发的支气管收缩，但是，与支气管扩张剂相比效果如何？ 目前还不清楚。

Randomized controlled trials comparing NCS to SCG in prophylactic treatment of exercise-induced bronchoconstriction were eligible.

仅纳入随机对照试验，比较NCS和SCG对运动诱发型支气管收缩的预防性治疗。

Inflammation plays an important role in the pathogenesis of exercise induced bronchoconstriction in asthmatic subjects but the evidence seems less strong in non-asthmatic subjects.

在气喘患者运动诱发支气管收缩的致病原因中，发炎扮演一个重要角色；但在非气喘患者，证据则较弱。

The objectives of this review were to evaluate the use of inhaled corticosteroids in the treatment of exercise induced bronchoconstriction in a systematic way.

本回顾的目的在于，以系统性方法评估吸入型皮质类固醇在治疗运动诱发支气管收缩时的使用。